Sanofi Pasteur S.A.
Records under this name other than the patents Sanofi Pasteur S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,871,807 | Method for Producing the Flu Virus Formerly held In force · High confidence | In force | High confidence | |
| US 11,554,170 | Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants Formerly held In force · High confidence | In force | High confidence | |
| US 8,377,682 | System for the Heterologous Expression of a Viral Protein in a Ciliate Host Cell Formerly held Lapsed on the fee record Ended Feb 19, 2025 · High confidence | Lapsed on the fee record | Ended Feb 19, 2025 | High confidence |
| US 9,132,181 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Lapsed on the fee record Ended Sep 15, 2023 · High confidence | Lapsed on the fee record | Ended Sep 15, 2023 | High confidence |
| US 9,005,623 | Flu Virus Hemagglutinin Specific Monoclonal Antibodies Lapsed on the fee record Ended Apr 14, 2023 · High confidence | Lapsed on the fee record | Ended Apr 14, 2023 | High confidence |
| US 7,863,013 | Method for the Production of Overproducing Staphylococcus Aureus Strains Lapsed on the fee record Ended Jan 4, 2023 · High confidence | Lapsed on the fee record | Ended Jan 4, 2023 | High confidence |
| US 10,137,145 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Lapsed on the fee record Ended Nov 27, 2022 · High confidence | Lapsed on the fee record | Ended Nov 27, 2022 | High confidence |
| US 8,557,537 | Method for the Production of Overproducing Staphylococcus Aureus Strains Lapsed on the fee record Ended Oct 15, 2021 · High confidence | Lapsed on the fee record | Ended Oct 15, 2021 | High confidence |
| US 8,506,971 | Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria Lapsed on the fee record Ended Aug 13, 2021 · High confidence | Lapsed on the fee record | Ended Aug 13, 2021 | High confidence |
| US 9,669,052 | Meningococcal Vaccine Based on Lipooligosaccharide (LOS) Originating from Modified Neisseria Meningitidis Strains of Immunotype L6 Lapsed on the fee record Ended Jun 6, 2021 · High confidence | Lapsed on the fee record | Ended Jun 6, 2021 | High confidence |